Physician profile
Jun Li
NPI 1235457961
$84,851.82
in general payments reported to CMS, 2019-2025
49 companies · $8,201 in 2025
The $8,201 reported for 2025 was more than what 87% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $6,492 · 2020: $6,173 · 2021: $4,519 · 2022: $31K · 2023: $21K · 2024: $7,390 · 2025: $8,201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Food and Beverage: $15K · Travel and Lodging: $2,019 · Grant: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,990.00 |
| Food and Beverage | $15,355.61 |
| Travel and Lodging | $2,018.78 |
| Grant | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $43,003.92 | 2021-2025 | Hawkone, In.Pact Admiral, Silverhawk |
| Boston Scientific Corporation | $13,389.32 | 2021-2025 | Ekosonic, General - Therapies, Ranger |
| Medtronic Vascular, INC. | $9,566.65 | 2019-2020 | |
| Abbott Laboratories | $5,037.93 | 2019-2025 | Supera, Esprit, Jeti All In One Non-Sterile Kit |
| Inari Medical, INC. | $4,135.07 | 2019-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Inquis Medical, INC. | $1,435.85 | 2024-2025 | Aventus |
| Abiomed | $1,372.93 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $973.40 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $512.92 | 2022-2025 | |
| Stryker Corporation | $444.66 | 2025 | Limflow System, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Angiodynamics, INC. | $436.15 | 2023-2025 | Auryon Laser System 100-120 Vac, Alphavac, Angiovac |
| Astrazeneca Pharmaceuticals Lp | $417.54 | 2019-2025 | Farxiga, Wainua, Brilinta |
| Pfizer INC. | $392.97 | 2019-2025 | |
| W. L. Gore & Associates, INC. | $382.75 | 2019-2024 | Gore Viabahn Endoprosthesis, C3 Delivery System |
| Amgen INC. | $358.41 | 2019-2025 | Repatha, Repatha |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $324.92 | 2019-2024 | Navicross, Glidesheath Slender, Glidewire |
| Biosense Webster, INC. | $307.44 | 2020-2024 | Carto 3, Qdot Micro Catheter |
| Atricure, INC. | $264.13 | 2024-2025 | Synergy Ablation System |
| E.R. Squibb & Sons, L.L.C. | $261.82 | 2020-2025 | Eliquis, Camzyos |
| Surmodics, INC. | $211.03 | 2022-2025 | Pounce Thrombectomy, Pounce Lp Thrombectomy, Pounce Xl Thrombectomy |
| Mimedx Group, INC. | $144.63 | 2025 | |
| Kerecis Limited | $137.61 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Ekos Corporation | $125.67 | 2019 | |
| Esperion Therapeutics, INC. | $113.05 | 2020-2025 | Nexletol |
| Shockwave Medical, INC | $110.60 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Gilead Sciences, INC. | $101.76 | 2022-2023 | |
| Cardiovascular Systems INC. | $93.19 | 2019 | |
| Merck Sharp & Dohme LLC | $77.61 | 2023 | Verquvo |
| Heartflow, INC. | $62.50 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $60.67 | 2019-2023 | Lifevest |
| Kiniksa Pharmaceuticals International, Plc | $55.82 | 2024 | Arcalyst |
| Novo Nordisk INC | $55.01 | 2025 | Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.88 | 2022-2025 | Jardiance |
| Regeneron Healthcare Solutions, INC. | $51.23 | 2019 | |
| Imperative Care, INC | $44.28 | 2025 | Prodigy Catheter |
| Teleflex LLC | $40.26 | 2019-2021 | |
| Kiniksa Pharmaceuticals, Ltd. | $36.74 | 2023 | Arcalyst |
| Portola Pharmaceuticals, LLC | $36.26 | 2019 | |
| Sanofi-Aventis U.S. LLC | $33.49 | 2022-2024 | |
| Cordis US Corp. | $29.45 | 2024 | Mynx Control |
| Lexicon Pharmaceuticals, INC. | $22.96 | 2024 | |
| Amarin Pharma, INC. | $22.82 | 2019 | |
| Bridgebio Pharma, INC. | $22.14 | 2025 | Attruby |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.96 | 2019 | |
| Chiesi USA, INC. | $21.45 | 2025 | Kengreal |
| Kestra Medical Technology Services, INC. | $21.37 | 2023 | Assure Wcd |
| Btg International INC. | $15.60 | 2019 | |
| Z-Medica, LLC | $10.00 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$350.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jun Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.